These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12762443)

  • 21. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
    Osman M; Ghosh SK
    J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The likelihood as statistical evidence in multiple comparisons in clinical trials: no free lunch.
    Korn EL; Freidlin B
    Biom J; 2006 Jun; 48(3):346-55. PubMed ID: 16845900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
    Jiang Z; Song Y; Shou Q; Xia J; Wang W
    Trials; 2014 Dec; 15():500. PubMed ID: 25528466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian hypothesis testing of four-taxon topologies using molecular sequence data.
    Sinsheimer JS; Lake JA; Little RJ
    Biometrics; 1996 Mar; 52(1):193-210. PubMed ID: 8934592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On comparing 2 correlated C indices with censored survival data.
    Han X; Zhang Y; Shao Y
    Stat Med; 2017 Nov; 36(25):4041-4049. PubMed ID: 28758216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian monitoring of clinical trials with failure-time endpoints.
    Rosner GL
    Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma.
    Johnson SR; Feldman BM; Pope JE; Tomlinson GA
    J Rheumatol; 2009 Feb; 36(2):323-9. PubMed ID: 19040308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixed and random effects selection in linear and logistic models.
    Kinney SK; Dunson DB
    Biometrics; 2007 Sep; 63(3):690-8. PubMed ID: 17403104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonparametric bayes testing of changes in a response distribution with an ordinal predictor.
    Pennell ML; Dunson DB
    Biometrics; 2008 Jun; 64(2):413-23. PubMed ID: 17764484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pattern-mixture models for multivariate incomplete data with covariates.
    Little RJ; Wang Y
    Biometrics; 1996 Mar; 52(1):98-111. PubMed ID: 8934587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time.
    Baker SG; Sargent DJ; Buyse M; Burzykowski T
    Biometrics; 2012 Mar; 68(1):248-57. PubMed ID: 21838732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian approach to subgroup identification.
    Berger JO; Wang X; Shen L
    J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hierarchical bayesian model for spatial prediction of multivariate non-gaussian random fields.
    Chagneau P; Mortier F; Picard N; Bacro JN
    Biometrics; 2011 Mar; 67(1):97-105. PubMed ID: 20374239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power priors based on multiple historical studies for binary outcomes.
    Gravestock I; Held L
    Biom J; 2019 Sep; 61(5):1201-1218. PubMed ID: 30325059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A semiparametric Bayesian approach to the random effects model.
    Kleinman KP; Ibrahim JG
    Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.